Anti-CEACAM1 antibody [EPR4049]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(11 Publications)
Rabbit Recombinant Monoclonal CEAM1 antibody. Suitable for IHC-P, IP, WB and reacts with Human samples. Cited in 11 publications.
View Alternative Names
CD66a, BGP, BGP1, CEACAM1, Cell adhesion molecule CEACAM1, Biliary glycoprotein 1, Carcinoembryonic antigen-related cell adhesion molecule 1, BGP-1, CEA cell adhesion molecule 1
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CEACAM1 antibody [EPR4049] (AB108397)
Unpurified ab108397 at 1/50 dilution staining CEACAM1 in Human kidney tissue by Immunohistochemistry, Paraffin-embedded tissue.
Heat mediated antigen retrieval was performed with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CEACAM1 antibody [EPR4049] (AB108397)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human clear cell carcinoma of kidney tissue sections labeling CEACAM1 with Purified ab108397 at 1 : 80 dilution (3.3 μg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). ImmunoHistoProbe one step HRP Polymer (ready to use)was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.
- IP
Unknown
Immunoprecipitation - Anti-CEACAM1 antibody [EPR4049] (AB108397)
ab108397 (purified) at 1 : 20 dilution (1.5μg) immunoprecipitating CEACAM1 in SW480 whole cell lysate.
Lane 1 (input) : SW480 (Human colorectal adenocarcinoma epithelial cell) whole cell lysate 10μg
Lane 2 (+) : ab108397 & SW480 whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab108397 in SW480 whole cell lysate
For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1 : 1000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-CEACAM1 antibody [EPR4049] (ab108397)
Predicted band size: 57 kDa
false
- WB
Lab
Western blot - Anti-CEACAM1 antibody [EPR4049] (AB108397)
Lanes 1-4 : Merged signal (red and green). Green - ab108397 observed at 100-180 kDa. Red - loading control ab8245 observed at 36 kDa.
ab108397 Anti-CEACAM1 antibody [EPR4049] was shown to specifically react with CEACAM1 in wild-type A549 cells. Loss of signal was observed when knockout cell line ab267047 (knockout cell lysate ab257389) was used. Wild-type and CEACAM1 knockout samples were subjected to SDS-PAGE. ab108397 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-CEACAM1 antibody [EPR4049] (ab108397) at 1/1000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
CEACAM1 knockout A549 cell lysate at 20 µg
Lane 2:
Western blot - Human CEACAM1 knockout A549 cell line (<a href='/en-us/products/cell-lines/human-ceacam1-knockout-a549-cell-line-ab267047'>ab267047</a>)
Lane 3:
A549 cell lysate at 20 µg
Lane 4:
MCF7 cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Predicted band size: 57 kDa
Observed band size: 100-180 kDa
false
- WB
Lab
Western blot - Anti-CEACAM1 antibody [EPR4049] (AB108397)
Lanes 1-4 : Merged signal (red and green). Green - ab108397 observed at 100-180 kDa. Red - loading control ab8245 observed at 36 kDa.
ab108397 Anti-CEACAM1 antibody [EPR4049] was shown to specifically react with CEACAM1 in wild-type A549 cells. Loss of signal was observed when knockout cell line ab267046 (knockout cell lysate ab257388) was used. Wild-type and CEACAM1 knockout samples were subjected to SDS-PAGE. ab108397 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-CEACAM1 antibody [EPR4049] (ab108397) at 1/1000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
CEACAM1 knockout A549 cell lysate at 20 µg
Lane 2:
Western blot - Human CEACAM1 knockout A549 cell line (<a href='/en-us/products/cell-lines/human-ceacam1-knockout-a549-cell-line-ab267046'>ab267046</a>)
Lane 3:
A549 cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Predicted band size: 29 kDa,57 kDa
Observed band size: 100-180 kDa,30 kDa
false
- WB
Lab
Western blot - Anti-CEACAM1 antibody [EPR4049] (AB108397)
The smear and multiple bands are consistent with what have been described in the literature PMID : 17071610, 26448580 and 30050594, due to a variety of splice variants and/or differential glycosylation
All lanes:
Western blot - Anti-CEACAM1 antibody [EPR4049] (ab108397) at 1/10000 dilution
Lane 1:
A549 (Human lung carcinoma epithelial cell) whole cell lysates at 20 µg
Lane 2:
SW480 (Human colorectal adenocarcinoma epithelial cell) whole cell lysates at 20 µg
Lane 3:
HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysates at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 57 kDa
Observed band size: 100-180 kDa
false
Related conjugates and formulations (1)
-
Anti-CEACAM1 antibody [EPR4049] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CEACAM1 influences cellular adhesion and immune responses by mediating cell-cell interactions. It forms homophilic dimers at the cell surface and it can participate in heterophilic interactions with other proteins making it part of complex cell signaling networks. These interactions regulate immune cell functions contributing to innate immune responses and cellular homeostasis. CEACAM1 also modulates angiogenesis endothelial cell permeability and apoptosis.
Pathways
CEACAM1 is involved in signaling and regulatory pathways important for immune surveillance and inflammation. It is a part of the TGF-beta signaling pathway affecting cellular proliferation and differentiation. CEACAM1 interacts with proteins such as SHP-1 and SHP-2 which are essential in modulating immune responses. Additionally CEACAM1 influences the MAPK/ERK pathway which plays a role in cell growth and survival.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in pharmacology 16:1579551 PubMed40520162
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biochemistry and biophysics reports 40:101833 PubMed39398537
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 15:1302761 PubMed38390332
2024
Applications
Unspecified application
Species
Unspecified reactive species
Translational oncology 27:101564 PubMed36252282
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cancer science 113:3476-3488 PubMed35879647
2022
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 297:101311 PubMed34666041
2021
Applications
Unspecified application
Species
Unspecified reactive species
The American journal of pathology 191:1774-1786 PubMed34303699
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancer science 111:1943-1957 PubMed32304268
2020
Applications
Unspecified application
Species
Unspecified reactive species
American journal of cancer research 9:2618-2633 PubMed31911850
2019
Applications
Unspecified application
Species
Unspecified reactive species
OncoTargets and therapy 12:10099-10105 PubMed31819504
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com